ExonHit Therapeutics Inc. Announces the Appointment of Its New Chief Financial Officer
11/5/2009 10:03:28 AM
More...
|
ExonHit Therapeutics Inc. Presents New Clinical Advances on Its Alzheimer’s Diagnostic and Therapeutic Programs
10/30/2009 8:59:50 AM
More...
|
ExonHit Therapeutics Inc. Presents New Clinical Advances on Its Alzheimer's Diagnostic and Therapeutic Programs
10/30/2009 6:28:53 AM
More...
|
ExonHit Therapeutics Inc. Strengthens Its Intellectual Property Position in the US
10/26/2009 9:46:28 AM
More...
|
ExonHit Therapeutics Inc. Will Participate to BioContact Quebec on Wednesday October 7th and Thursday October 8th
10/2/2009 6:56:36 AM
More...
|
ExonHit Therapeutics Inc. Presents Promising First Patient Results For EHT 0202, Its Alzheimer's Candidate Drug
9/14/2009 2:49:10 PM
More...
|
ExonHit Therapeutics Inc. -- First Half 2009 Results
7/30/2009 9:23:41 AM
More...
|
ExonHit Therapeutics Inc. Announces the Departure of Its Chief Financial Officer
6/26/2009 7:20:12 AM
More...
|
ExonHit Therapeutics Inc. Announces Last Patient out for EHT 0202 Phase IIa Study in Alzheimer
6/16/2009 9:02:08 AM
More...
|
ExonHit Therapeutics Inc. and Institut Gustave Roussy Announce the Signing of a License Agreement for Novel Breast Cancer Diagnostic Assay
5/27/2009 7:32:36 AM
More...
|
|